Pharming Group NV (Pharming) is a Netherlands-based biotechnology company. The Company operates through two business segments, including Recombinant proteins, and DNage. Pharming focuses on the development, production and commercialization of human therapeutic proteins to be used as innovative therapies. The Company's products are aimed at treatments for genetic disorders and surgical and traumatic bleeding. Pharming's technologies include novel transgenic platforms for the production of biopharmaceuticals, as well as technology and processes for the purification and formulation of these biopharmaceuticals. The Company's commercial partners are: Santarus, Sobi, MegaPharm, Eczacibasi, Transmedic and Hyupjin. The Company operates worldwide. In March 2014, it announced downsizing of the Dutch operations following from strategic re-emphasis on collaborative development efforts and out-sourcing of non-core activities.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: N/A
- Sub-Industry: N/A
- Symbol: NASDAQ:PHGUF
- CUSIP: N/A
- Web: www.pharming.com
- 52 Week Range: $0.18 - $0.40
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 12.09
- P/E Growth: 0.0000
- Annual Revenue: $17.31 million
- Price / Sales: N/A
- Book Value: $0.07 per share
- Price / Book: 5.49
Frequently Asked Questions for Pharming Group (NASDAQ:PHGUF)
What is Pharming Group's stock symbol?
Pharming Group trades on the NASDAQ under the ticker symbol "PHGUF."
How were Pharming Group's earnings last quarter?
Pharming Group (NASDAQ:PHGUF) released its quarterly earnings data on Thursday, March, 5th. The company reported $0.05 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.04 by $0.01. View Pharming Group's Earnings History.
Who are some of Pharming Group's key competitors?
Some companies that are related to Pharming Group include Accuray Incorporated (ARAY), Pacific Biosciences of California (PACB), RadNet (RDNT), Agenus (AGEN), Aurinia Pharmaceuticals (AUPH), Advaxis (ADXS), ChemoCentryx (CCXI), Corbus Pharmaceuticals Holdings (CRBP), Aquinox Pharmaceuticals (AQXP), Oxford Immunotec Global PLC (OXFD), GlycoMimetics (GLYC), Ocular Therapeutix (OCUL), SurModics (SRDX), Zogenix (ZGNX), Nantkwest (NK), Merus NV (MRUS), Minerva Neurosciences (NERV) and Edge Therapeutics (EDGE).
How do I buy Pharming Group stock?
Shares of Pharming Group can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Pharming Group stock cost?
One share of Pharming Group stock can currently be purchased for approximately $0.36.
Consensus Ratings for Pharming Group (NASDAQ:PHGUF) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Pharming Group (NASDAQ:PHGUF)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Pharming Group (NASDAQ:PHGUF)Earnings History by Quarter for Pharming Group (NASDAQ:PHGUF)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Earnings Estimates for Pharming Group (NASDAQ:PHGUF)
Current Year EPS Consensus Estimate: $-0.0300 EPS
Next Year EPS Consensus Estimate: $0.0300 EPS
Dividend History for Pharming Group (NASDAQ:PHGUF)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Pharming Group (NASDAQ:PHGUF)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Pharming Group (NASDAQ:PHGUF)
Latest Headlines for Pharming Group (NASDAQ:PHGUF)
Pharming Group (PHGUF) Chart for Saturday, May, 27, 2017